FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely obstetrics, and may be used for preventing preeclampsia. That is ensured by prescribing nicotinic acid tablets 50 mg 2 times a day for 30 days combined with intravenous introductions of actovegin 400 mg/day in 5% glucose 100 ml for the first 5 days in a pregnant woman up to 9 weeks of pregnancy.
EFFECT: invention provides prevention of eclampsia and severe preeclampsia ensured by metabolic and antioxidant action of the preparations used in the presented therapeutic scheme.
4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTION OF DEVELOPING SEVERE PREECLAMPSIA | 2012 |
|
RU2481578C1 |
| METHOD OF PREVENTING FETAL CONGENITAL MALFORMATIONS | 2011 |
|
RU2465903C1 |
| METHOD FOR PREVENTING CHRONIC HYPOXIA AND FOETAL DEVELOPMENT RETARDATION | 2018 |
|
RU2699559C2 |
| METHOD OF TREATING PATIENTS WITH REFRACTORY PREGNANCY LOSS IN FIRST TRIMESTER | 2010 |
|
RU2452481C1 |
| METHOD OF PREVENTION OR TREATMENT OF INTRAUTERINE GROWTH RETARDATION SYNDROME | 2011 |
|
RU2473339C1 |
| METHOD FOR PREDICTING THE RISK OF DEVELOPING UNFAVOURABLE MATERNAL OUTCOMES DURING PREGNANCY, CHILDBIRTH AND THE POSTPARTUM PERIOD | 2023 |
|
RU2803129C1 |
| METHOD FOR PREDICTING THE DEVELOPMENT OF CRITICAL CONDITIONS OF WOMEN DURING CHILDBEARING AND DURING THE PUERPERIUM | 2017 |
|
RU2647459C1 |
| METHOD FOR DIAGNOSING COGNITIVE IMPAIRMENTS IN PREGNANT WOMEN WITH HYPERTENSIVE DISORDERS | 2022 |
|
RU2792740C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
| METHOD OF PREVENTING SEVERE FORMS OF OBSTETRICAL PATHOLOGY | 2010 |
|
RU2422149C1 |
